Market revenue in 2023 | USD 309.0 million |
Market revenue in 2030 | USD 513.5 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 65.24% in 2023. Horizon Databook has segmented the France veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary API manufacturing market is anticipated to exhibit high growth in France over the forecast period. This can be attributed to the growing adoption of pets and the need for increasing livestock production.
Furthermore, France ranks third, after Germany and Russia, to have the highest number of companion animals. Moreover, the availability of abundant scientific & technical expertise and increased R&D & launch of international projects are expected to create growth opportunities in France.
Furthermore, the presence of government institutions that focus on ensuring the safety of veterinary medicinal products, such as the French Agency for Veterinary Medicinal Products (ANMV), is contributing to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the France veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into France veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account